-
-
-
-
-
-
-
Tonix publishes TONMYA pharmacokinetics study in peer-reviewed journal
-
-
-
-
-
-
-
Tonix launches TONMYA fibromyalgia treatment in US pharmacies
-
-
-
-
-
-
-
Tonix Pharmaceuticals Announces In-licensing Phase 2/3-Ready Monoclonal Antibody Designed for Seasonal Prevention of Lyme Disease (TNX-4800)
-
-
-
-
-
-
-
Tonix to present mpox vaccine data at Vienna congress
-
-
-
-
-
-
-
Tonix Pharma (TNXP) Launches TONIX ONE
-
-
-
-
-
-
-
Tonix’s TNX-1500 Shows Promise in Preventing Organ Transplant Rejections of Either Human or Pig Organs; Autoimmune Diseases Also a Target
-
-
-
-
-
-
-
Tonix's TNX 102-SL Could Offer New Hope of Pain Relief Without Narcotics for Fibromyalgia Sufferers
-
414,340 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

